Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Change in Accured Expenses (2018 - 2025)

Exagen's Change in Accured Expenses history spans 8 years, with the latest figure at $681000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 32.37% year-over-year to $681000.0; the TTM value through Dec 2025 reached $251000.0, up 288.72%, while the annual FY2025 figure was $251000.0, 288.72% up from the prior year.
  • Change in Accured Expenses reached $681000.0 in Q4 2025 per XGN's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q3 2023 to a low of -$1.4 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $109850.0, with a median of $300000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: crashed 645.45% in 2022, then surged 903.37% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $446000.0 in 2021, then crashed by 387.22% to -$1.3 million in 2022, then skyrocketed by 138.8% to $497000.0 in 2023, then skyrocketed by 102.62% to $1.0 million in 2024, then tumbled by 32.37% to $681000.0 in 2025.
  • Per Business Quant, the three most recent readings for XGN's Change in Accured Expenses are $681000.0 (Q4 2025), $1.2 million (Q3 2025), and -$192000.0 (Q2 2025).